Welcome back to E&O Fridays, a paying subscribers-only weekly newsletter focused on the world of digital pharma products and FDA-regulated digital health. Thanks to everyone who sent over names of digital health startups that spun out of pharmaceutical companies. (I received a lot of emails.) Working on a round-up of those for next week, so hit reply if you think I might be missing any.

E&O Fridays.

OK, here's what's happening this week in the world of pharma digital products and FDA-regulated digital health:

The big hire this week goes to Amalgam Rx, which just announced that the COO of CMS, Jennifer Main, will join the company next month as its COO and CFO.
Meanwhile, investment dollars continue to flow: Happify Health announced a sizeable $73 million Series D led by Deerfield Management Company.
The big product launch this week goes to AstraZeneca, which officially

Paying Subscribers Only

It's a good one, too.

This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!

Newsletters

That weird FDA de-regulatory notice.

E&O Fridays.

Paying Subscribers Only

Full access to E&O's research and newsletters.

That weird FDA de-regulatory notice.

E&O Fridays.

Paying Subscribers Only

Full access to E&O's research and newsletters.

New! E&O's free weekly newsletter.